Medpace Holdings reported $707.3 million in Q2 2026 revenue, up 17.2% year-over-year, alongside $795.7 million in net new business awards, showcasing the contract research organization's strong financial momentum.
Medpace Holdings reported $707.3 million in Q2 2026 revenue, up 17.2% year-over-year, alongside $795.7 million in net new business awards, showcasing the contract research organization's strong financial momentum.